Trial Profile

A Phase 1b Trial in Asthma for EDP1867

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 21 Apr 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs EDP 1867 (Primary)
Indications Allergic asthma
Focus Adverse reactions
Sponsors Evelo Biosciences

Most Recent Events

14 Apr 2022 According to an Evelo Biosciences media release, company will put the EDP1867 program on hold to focus its efforts on its lead inflammation programs EDP1815 and EDP2939.
11 May 2020 According to an Evelo Biosciences media release,Initiation of Phase 1b trial of EDP1867 in atopic diseases in 1Q 2021
13 Feb 2020 According to an Evelo Biosciences media release, this study is expected to start in the second half of 2020.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com